Drug development: a healthy pipeline (Nature)

After decades without any specific drugs for irritable bowel syndrome (IBS), the first few years of the millennium brought hope in the form of two approvals. But this new era turned out to be a false dawn. In February 2000, alosetron became the first drug to be approved by the US Food and Drug Administration (FDA) for use in women who had IBS with diarrhoea (IBS-D). But within a few months there were reports of serious complications among people who were taking the drug and several deaths. Alosetron was withdrawn that November.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s